Introduction {#Sec1}
============

The genome is the complex of the genetic information of a cell and in eukaryota (and thus in humans) is stored in the nucleus and mitochondria \[[@CR1]\]. While mitochondrial DNA (mtDNA) sequence has been known since 1981 \[[@CR2]\], the draft sequence of the nuclear human genome was first published in February 2001 \[[@CR3], [@CR4]\]. The last human reference genome GRCh38/hg38 was released in December 2013 by the Genome Reference Consortium (GRC) and is the most comprehensive and highest quality mosaic haploid representation compared to previous reference assembly versions, addressing issues about gaps, variants and component and tiling path errors; in addition, for the first time, it contains sequence-based representations for centromeres and telomeres \[[@CR5], [@CR6]\].

The fact that very long molecules of human DNA can be contained, following accurate and multiple rounds of folding, within the very limited space of the nucleus, has always attracted attention. In 1990 when sequencing of human genome was just at its beginning, geneticist Jérôme Lejeune affirmed that "*we have got 2 meters of so to speak magnetic tape in which everything is coded*" (Louisiana Legislature, House Committee on the Administration of Criminal Justice, June 7, 1990). Traditionally, it has actually roughly been estimated over the last decades that the total length of human diploid DNA is around 2 m (Table [1](#Tab1){ref-type="table"}) \[[@CR7]--[@CR13]\]. The base composition is usually specified quoting the percentage of guanine (G) and cytosine (C) of a DNA molecule, or GC content \[[@CR1]\] and was first estimated through the buoyant density centrifugation \[[@CR14]\]. The GC content has been well studied across organisms \[[@CR15]--[@CR19]\], showing its relationships with various genomic characteristics \[[@CR20]--[@CR24]\] and with gene structures such as exons and introns \[[@CR25]--[@CR27]\], for example showing that G-rich repeats are a consistent feature of human ultra-short introns \[[@CR28], [@CR29]\].Table 1Human genome length estimatesReferencesMetersWeb sites <http://hypertextbook.com/facts/1998/StevenChen.shtml>Diploid: 1.5--3 <http://www.madsci.org/posts/archives/feb99/917376364.Mb.r.html>Haploid: 1 <http://book.bionumbers.org/how-big-are-genomes/>Diploid: 2 <https://publications.nigms.nih.gov/insidelifescience/genetics-numbers.html>Diploid: 1.8^a^ <http://scienceline.ucsb.edu/getkey.php?key=144>Haploid: 1.8Articles \[[@CR8]\]Diploid: 2 \[[@CR9]\]Diploid: 2 \[[@CR10]\]Haploid: 1.5Books \[[@CR7]\]Diploid: 2 \[[@CR11]\]Haploid: 1 \[[@CR12]\]Diploid: 2 \[[@CR13]\]Diploid: 2^a^This value was converted from the stated 6 feet

The availability of a high-quality reference sequence for the human genome currently offers the possibility to provide an accurate evaluation of these parameters. In this work we propose revised estimations for the length, weight and GC content of the reference human genome and of individual chromosomes, including mtDNA, in a standard human diploid cell and in a reference human being. Moreover, in this paper we discuss the meaning of the obtained results and we formulated a method to calculate the relative GC content in the whole messenger RNA set of sequences and in transcriptomes, comparing different tissues and organisms.

Main text {#Sec2}
=========

Methods {#Sec3}
-------

### Human genome length and weight calculations {#Sec4}

Lengths in centimeters (cm) and weight in picograms (pg) of all 24 human chromosome and mtDNA sequences were calculated as detailed in Additional file [1](#MOESM1){ref-type="media"}: Additional Methods.

### GC content analysis {#Sec5}

The genomic GC content was calculated among the certain bases for the 24 chromosomes and for mtDNA as detailed in Additional file [1](#MOESM1){ref-type="media"}: Additional Methods.

The "Transcriptomic GC Analysis" (TGCA) software was developed here to study the possible variation of GC content in the expression of whole transcriptomes.

Human quantitative transcriptome maps were previously obtained from publicly available microarray datasets analysed through TRAM (Transcriptome Mapper) software \[[@CR30]\] as described \[[@CR31]--[@CR33]\]. Since quantitative gene expression values may anticipate mutational effects that will most likely affect a given human tissue \[[@CR34]\], we compared a pathologic cell type with its normal counterpart and a whole organ with one of its subregions (Additional file [1](#MOESM1){ref-type="media"}: Additional Methods). For each analysis, only genes for which an expression value is available in both biological conditions were used. For each gene, the longest human mRNA sequence was obtained from the latest version of human 5′\_ORF_Extender software \[[@CR35]\] (Additional file [1](#MOESM1){ref-type="media"}: Additional Methods).

Since TRAM and 5′\_ORF_Extender were implemented for other organisms \[[@CR36], [@CR37]\], TGCA software itself was implemented with the purpose to be easily used with any sequence and expression dataset of any organism. Thus, we performed GC calculations on other representative species genomes: *Danio rerio*, *Caenorhabditis elegans*, *Saccharomyces cerevisiae* and *Escherichia coli* (Additional file [1](#MOESM1){ref-type="media"}: Additional Methods).

Results {#Sec6}
-------

### Human nuclear genome length and weight {#Sec7}

Individual chromosome lengths in bp and cm are given in Table [2](#Tab2){ref-type="table"}. Certain base counts and uncertain base composition estimations given in Additional file [2](#MOESM2){ref-type="media"}: Table S1 were used to calculate each chromosome weight, obtaining the results shown in Table [2](#Tab2){ref-type="table"}. The length and weight sums of the 24 chromosomes (22 autosomes and X and Y chromosomes) were used in order to proportionately estimate the length and weight of the unplaced bases, improving whole genome calculation accuracy (Table [2](#Tab2){ref-type="table"}). Data for the previous assembly (GRCh37.p13) are also given in Additional file [3](#MOESM3){ref-type="media"}: Table S2 and Additional file [4](#MOESM4){ref-type="media"}: Table S3. The chromosomes varying to a greater extent between the two assembly versions are chromosomes 9 and Y (GRCh38 has 2.8 Mb and 2.1 Mb less than GRCh37, respectively) and chromosomes 17 and 18 (GRCh38 has 2.1 Mb and 2.3 Mb more than GRCh37, respectively).Table 2Length, weight and GC content of human chromosomes, genome and mitochondrial DNAChromosomeLength (bp)Length (cm)Weight (pg)Weight (fg)GC%1*248,956,4228.14*± 0.08*0.25254.57*41.722242,193,5297.92 ± 0.08*0.25*247.6540.233198,295,5596.48 ± 0.060.20202.7639.674190,214,5556.22 ± 0.060.19194.49*38.24*5181,538,2595.93 ± 0.060.19185.6339.516170,805,9795.58 ± 0.050.17174.6539.617159,345,9735.21 ± 0.050.16162.9440.708145,138,6364.74 ± 0.050.15148.4140.169138,394,7174.52 ± 0.040.14141.5141.2810133,797,4224.37 ± 0.040.14136.8141.5411135,086,6224.42 ± 0.040.14138.1341.5412133,275,3094.36 ± 0.040.14136.2840.7713114,364,3283.74 ± 0.040.12116.9438.5514107,043,7183.50 ± 0.030.11109.4640.8315101,991,1893.33 ± 0.030.10104.2942.031690,338,3452.95 ± 0.030.0992.3844.581783,257,4412.72 ± 0.030.0985.1445.321880,373,2852.63 ± 0.030.0882.1839.781958,617,6161.92 ± 0.020.0659.95*47.94*2064,444,1672.11 ± 0.020.0765.9043.8021*46,709,9831.53* ± 0.01*0.0547.76*40.942250,818,4681.66 ± 0.02*0.05*51.9747.00X156,040,8955.10 ± 0.050.16159.5539.53Y57,227,4151.87 ± 0.020.0658.5240.03Total (1--22, X, Y)^a^3,088,269,832100.96 ± 0.973.163157.8740.87Unplaced153,667,0285.02 ± 0.050.16157.13Total male (46, XY)^b^6,270,605,410205.00 ± 1.976.416411.9440.91Total female (46, XX)^b^6,369,418,890208.23 ± 2.006.516512.9840.88Mean (male and female)6,320,012,150206.62 ± 1.996.466462.4640.89mtDNA16,5690.000540.0000170.0244.36Mean mtDNA per cell56,793,7271.86 ± 0.020.0658.08Italics: minimum and maximum valuesBp, base pairs; cm, centimeters (variation was calculated considering the uncertainty of the bp number per DNA helical turn \[[@CR55]\]); pg, picograms; fg, femtograms; GC%, percentage of G (guanine), C (cytosine) and S (G or C) among certain bases^a^The total was obtained summing lengths and weights for the 24 types of human linear DNA molecules and used in order to proportionately calculate the length and weight of unplaced bases, improving whole genome calculation accuracy^b^Total for a male or female diploid cell, including a double complement of unplaced bases

Considering a mean length in a diploid cell of 206.62 cm and the latest estimation of a mean of 3 × 10^12^ nucleated cells for a reference human being \[[@CR38], [@CR39]\], the total extension in length of all nuclear DNA molecules present in a single human individual is of about 6.20 billion km (6.20 × 10^12^ m) and is sufficient to cover the Earth-Sun distance (<https://cneos.jpl.nasa.gov/glossary/au.html>) more than 41 times. Considering a mean weight in a diploid cell of 6.46 pg, the genome weight summed across nucleated human cells would be about 19.39 g, almost the weight of 100 carats (<https://sizes.com/units/carat.htm>).

### The mitochondrial genome {#Sec8}

Applying all the calculations previously performed for the nuclear genome, the human mtDNA length, weight and GC content were estimated (Table [2](#Tab2){ref-type="table"}).

On average, a human cell could contain from a minimum of 2,845,394 ± 204,296 bp, 0.09 ± 0.0067 cm and 0.0029 ± 0.00021 pg to a maximum of 110,742,060 ± 4,568,736.06 bp, 3.62 ± 0.15 cm and 0.11 ± 0.0047 pg of mtDNA in total, depending on the uncertainty of the number DNA molecules per cell \[[@CR40]\] (Additional file [1](#MOESM1){ref-type="media"}: Additional Methods). Therefore, the mtDNA, despite its size being greatly reduced in comparison to those of nuclear DNA (1/195,663 compared to haploid nuclear genome), constitutes a significant share of total DNA of a human cell: about 0.90--1.21% (diploid cell), being able to represent at least 52.03% of the DNA in the case of a mature oocyte.

### GC content analysis {#Sec9}

The human GC contents calculated among the certain bases (A, T, W, G, C, and S) counted in the 24 human chromosomes excluding the 150,630,700 uncertain bases are shown in Table [2](#Tab2){ref-type="table"} (Additional file [4](#MOESM4){ref-type="media"}: Table S3 for GRCh37.p13). Among the other investigated species, the calculated chromosome numbers, total genome bp lengths and genomic GC contents (Table [3](#Tab3){ref-type="table"}) are in accordance with previous reports (Additional file [5](#MOESM5){ref-type="media"}: Table S4).Table 3Genomic, mRNA and transcriptomic GC contents in the investigated human conditions and other speciesSpeciesGenomic GC%mRNA GC%Transcriptomic GC%∆GC%^(mRNA−Genomic)^∆GC%^(Transcriptomic−mRNA)^*H. sapiens* DS-AMKL40.8948.8048.217.91− 0.59*H. sapiens* MK49.277.910.47*H. sapiens* Hippocampus48.8348.857.940.03*H. sapiens* Brain48.927.940.09*D. rerio* Brain36.6345.7045.409.08− 0.30*C. elegans*35.4442.2143.226.771.00*S. cerevisiae*38.3039.6340.211.340.58*E. coli*50.7951.9952.131.200.15Genomic GC%: percentage of G (guanine), C (cytosine) and S (G or C, present only in *H. sapiens* and *D. rerio* assemblies); for *H. sapiens* the mean GC content between male and female genomes was used; mRNA GC%: percentage of G and C in the analysed messenger RNA set having an expression value together with mRNA sequences available (see "[Methods](#Sec3){ref-type="sec"}" section for details); transcriptomic GC%: percentage of G and C in the sum of each mRNA GC count multiplied by its mean expression value for each biological condition; ∆GC%^(mRNA−Genomic)^: difference between mRNA and genomic GC%; ∆GC%^(Transcriptomic−mRNA)^: difference between transcriptomic and mRNA GC%

Human Down Syndrome (DS) Acute Megakaryoblastic Leukemia (AMKL) blasts and euploid megakaryoblasts (MK) transcriptome maps have an expression value in both conditions together with mRNA sequences available for 16,547 genes. This value for whole human hippocampus and whole brain transcriptome maps is of 17,579 genes. Among the other investigated species, this value is of 6642 genes for *D. rerio* brain, 19,281 for *C. elegans*, 4673 for *S. cerevisiae* and 2426 for *E. coli*. The mRNA GC contents calculated in these subsets using TGCA software are given in Table [3](#Tab3){ref-type="table"}. For each biological condition, each mRNA GC absolute count was then multiplied by the corresponding expression value. The sum of these values related to each transcriptome map gives the transcriptomic GC content (Table [3](#Tab3){ref-type="table"}). mRNA and transcriptomic GC contents for each chromosome in DS-AMKL and MK conditions are given in Additional file [6](#MOESM6){ref-type="media"}: Table S5. DS-AMKL condition has 7 chromosomes (9, 11, 20, 17, 16, 22, 19) with a transcriptomic GC content higher than 48.80 which is the total mRNA GC % (the maximum is 56.26% of chr19), while MK condition has 9 chromosomes (7, 15, 9, 11, 20, 17, 22, 16, 19) with a transcriptomic GC content higher than that value (the maximum is 59.02% of chr19, which is a very high value).

Discussion {#Sec10}
----------

In this work we have determined, to the best of our knowledge, basic parameters describing the normal human reference genome: the length, expressed in terms of both bp and unit of length (cm, m), weight (in unit of mass, pg) and relative GC content expressed in percentages, for the whole human nuclear genome, for each chromosome and for mtDNA.

We have based our calculations on the GRCh38 assembly, which is longer and more contiguous than previous reference assembly versions and provides a sequence-based representation for genomic features such as centromeres and telomeres for the first time \[[@CR5]\], which, although variable among cell types and ages, would affect our estimates to a small extent. However, the human genetic diversity ranges from the single-nucleotide variation to large chromosomal events \[[@CR41], [@CR42]\]. Following the sequencing of 1000 human genomes \[[@CR43]\], a recent analysis estimated \~ 20 million bases of sequence variation in a typical diploid genome \[[@CR43]\]. Applying this order of magnitude of variation to our estimates, a proportional variability among individuals of ± 0.65 cm and 0.02 pg for the length and weight of a human mean diploid genome can be assumed.

Our results are not far from previous rough estimates (Table [1](#Tab1){ref-type="table"}), however the more accurate determination of the human genome length and weight might offer interesting possibilities. A recent analysis of 70 genomes from prokaryotes to primates showed that five informational laws about genome structure complexity may have been found \[[@CR44]\], suggested by indexes based on the value k = lg~2~(n), where k is the length of a string occurring in the genome and n is the genome length \[[@CR44]\]. Applying our analysis to other genomes would be useful to update these indexes. Another interesting possibility offered by the knowledge of human nuclear genome length is the derivation of the total human DNA volume, in order to estimate the efficiency of DNA in data storage, resulted to be in the order of 10^4^ fold superior in comparison to the most currently advanced hard disks (Additional file [7](#MOESM7){ref-type="media"}: Discussion). The genome weight is a parameter useful for the correlation with the DNA extraction yields through different methods \[[@CR45]\].

Regarding GC content analysis at genomic level, our results are in agreement with a recent study \[[@CR6]\]. Through the implementation of TGCA software we have also determined the GC content at mRNA and transcriptomic levels for the first time, a novel concept we propose here, which is the GC percentage calculated in the mRNA amount actually expressed in a tissue. The human genomic GC content results to be much lower than mRNA GC content. mRNA GC content is in turn similar to the transcriptomic GC content. This has been confirmed also in *D. rerio* and *C. elegans* and to a lesser extent in *S. cerevisiae* and in *E. coli*. Overall, it seems that the GC composition of highly and poorly expressed genes in specific tissues affects the mRNA GC content to a small extent and a global compensation between them may exist.

Comparing different biological conditions, the greatest deviation from the mRNA GC content was found in a condition of aneuploidy and leukaemia (DS-AMKL). Interestingly, DS-AMKL transcriptomic GC content skews in a greater extent from the transcriptomic GC content of the healthy euploid counterpart of MK cells. Recent works conducted on DS subjects showed typical alterations of the metabolome and whole transcriptome \[[@CR46], [@CR47]\]. Chromosome 21 GC content is one of the closest to the mean genomic GC content, thus the presence of a third copy of chromosome 21 would not cause a great change in GC composition at genomic level. Since the duplication of at least a restricted region of human chromosome 21 is associated to DS \[[@CR48]\], further studies are necessary to determine whether the duplication of this chromosome 21 region and/or the leukaemia condition is responsible for this deviation pattern. For example, a recent work showed a high expression of high-GC-content mRNAs in psoriasis lesion transcriptome, while resolving lesions had a low expression of these mRNAs \[[@CR49]\]. More in-depth analysis will be needed to validate the use of these indexes as indicators in the comparison of disease versus normal conditions.

Genomic, mRNA and transcriptomic GC content determination can be useful in DNA and RNA sequencing analyses where GC content bias for the Illumina sequencing technology has been documented as likely introduced at the library preparation step, resulting in confounding DNA copy number studies and expression fold-change estimates \[[@CR50]\].

In conclusion, we provide an update on fundamental human genome parameters and a first characterisation of the mRNA and transcriptome GC contents. Our results may represent a solid basis for further investigations on human structural and functional genomics \[[@CR29], [@CR51]\] while also providing a framework for the comparative analysis of other genomes.

Limitations {#Sec11}
===========

Determination of the length, weight and relative GC content of genome is subjected to the accuracy of the genome assembly and to the variability existing among individuals \[[@CR41]\]. Regarding mtDNA, although its sequence has been exactly determined, the mtDNA molecule copy number per cell is of difficult estimation \[[@CR52]\]. Regarding GC content at mRNA and transcriptomic levels, the analysis is limited to genes for which an expression value together with the corresponding longest mRNA nucleotide sequence is publicly available. Finally, mRNA 5´ region is known to have a composition bias \[[@CR53]\] and a better delimitation of this sequence may be necessary \[[@CR54]\].
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**Additional file 1: Additional Methods.** Human genome length and weight calculations, human GC content analysis and GC content analysis in other species. Detailed description of the genome length and weight calculations and of the GC content analysis for the human genome and for *Danio rerio*, *Caenorhabditis elegans*, *Saccharomyces cerevisiae*, and *Escherichia coli.* **Additional file 2: Table S1.** Nucleotide counts in the 24 human chromosomes and estimation of uncertain bases, based on GRCh38.p10. Nucleotide counts for the 24 human chromosomes and estimation of uncertain bases necessary for the genome length and weight calculations and for the GC content analysis, based on the most recent human genome assembly, obtained as described in detail in Additional file [1](#MOESM1){ref-type="media"}: Additional Methods file. **Additional file 3: Table S2.** Nucleotide counts in the 24 human chromosomes and estimation of uncertain bases, based on GRCh37.p13. Nucleotide counts for the 24 human chromosomes and estimation of uncertain bases necessary for the genome length and weight calculations and for the GC content analysis, based on the previous human genome assembly, obtained as described in detail in Additional file [1](#MOESM1){ref-type="media"}: Additional Methods file. **Additional file 4: Table S3.** Length, weight and GC content of human chromosomes, genome and mitochondrial DNA, based on GRCh37.p13. Length, weight and GC content of human chromosomes, genome and mitochondrial DNA, based on the previous human genome assembly, obtained as described in detail in Additional file [1](#MOESM1){ref-type="media"}: Additional Methods file. **Additional file 5: Table S4.** Accordance of our calculations with previous reports. Accordance with previous reports of our calculations of the number of chromosomes and the total genome length for *Danio rerio*, *Caenorhabditis elegans*, *Saccharomyces cerevisiae*, and *Escherichia coli* obtained as described in detail in Additional file [1](#MOESM1){ref-type="media"}: Additional Methods file. **Additional file 6: Table S5.** Genomic, mRNA and transcriptomic GC contents per chromosome in human Down Syndrome (DS) acute megakaryoblastic leukemia (AMKL) blasts and euploid megakaryoblasts (MK) conditions. Genomic, mRNA and transcriptomic GC contents per chromosome in human Down Syndrome (DS) acute megakaryoblastic leukemia (AMKL) blasts and euploid megakaryoblasts (MK) conditions obtained as described in detail in Additional file [1](#MOESM1){ref-type="media"}: Additional Methods file. **Additional file 7: Discussion.** In-depth discussion of obtained results.

mtDNA

:   mitochondrial DNA

IHGSC

:   International Human Genome Sequencing Consortium

GRC

:   Genome Reference Consortium

G

:   guanine

C

:   cytosine

m

:   meters

A

:   adenine

T

:   thymine

W

:   A or T

G

:   guanine

C

:   cytosine

S

:   G or C

N

:   any nucleotide

cm

:   centimeters

bp

:   base pairs

nm

:   nanometers

pg

:   picograms

kg

:   kilograms

mRNA

:   messenger RNA

TGCA

:   Transcriptomic GC Analysis

TRAM

:   Transcriptome Mapper

DS

:   Down Syndrome

AMKL

:   acute megakaryoblastic leukaemia

MK

:   megakaryoblasts

Mbp

:   megabases

Gbp

:   gigabases

g

:   grams

CNVs

:   copy number variants

AP developed the software, collected the data, performed the analysis, and wrote the manuscript draft. MCP and FA collected the data and critically revised the results of the analysis. PS designed the work, tested the software and wrote the manuscript draft. MC and LV supervised the project and critically revised the manuscript. All authors contributed to the interpretation of data. All authors agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature. All authors read and approved the final manuscript.

Acknowledgements {#FPar1}
================

We wish to sincerely thank the Fondazione Umano Progresso, Milano, Italy for their fundamental support to our research on trisomy 21 and to this study.

We thank all the other people that very kindly contributed by individual donations to support part of the fellowships as well as hardware and software. In particular, we are profoundly grateful to Matteo and Elisa Mele, to the Costa family, "Gruppo Arzdore", Parrocchia di Dozza and Associazione Turistica Pro Loco di Dozza (Dozza, Bologna, Italy) and to Rina Bini.

We are grateful to Kirsten Welter for her kind and expert revision of the manuscript.

Competing interests {#FPar2}
===================

The authors declare that they have no competing interests.

Availability of data and materials {#FPar3}
==================================

The datasets generated and analysed during the current study are publicly available online at <http://apollo11.isto.unibo.it/software/>. Some of them are also are available within the article and its additional information files.

The Python executable script used to count any type of nucleotide letter, the FileMaker stand-alone database with which the counts were analysed and the tutorial are publicly available at <http://apollo11.isto.unibo.it/software/>.

TGCA software was developed within the FileMaker Pro Advanced environment (FileMaker, Santa Clara, CA, version 12). Mac OS X and Windows stand-alone software (TGCA versions pre-loaded with transcriptome and sequence data and empty) are freely available to all for basic use at <http://apollo11.isto.unibo.it/software/>, including the FileMaker runtime and a tutorial.

Project name: TGCA_Software.

Project home page: <http://apollo11.isto.unibo.it/software/>.

Programming language: Python and FileMaker.

Operating systems: Mac OS X and Windows.

Minimum software requirements: Mac OS X 10.6, OS X Lion 10.7, OS X Mountain Lion 10.8; Windows XP Professional, Home Edition (Service Pack 3); Windows Vista Ultimate, Business, Home Premium (Service Pack 2); Windows 7 Ultimate, Professional, Home Premium; Windows 8 Standard and Pro edition.

Minimum system requirements: Mac OS X 10.6, Intel-based Mac CPU (Central Processing Unit), 1 GigaByte (GB) of RAM (Random Access Memory), 1024 × 768 or higher resolution video adapter and display. Windows XP Professional, Home Edition (Service Pack 3), 700 MegaHertz (MHz) CPU or faster, 256 MegaBytes (MB) of RAM, 1024 × 768 or higher resolution video adapter and display.

A connection to the Internet is required to display the software tutorial and to download data for set up, but not to run the tool.

Any restrictions to use by non-academics: freely available to all for basic use.

Consent to publish {#FPar4}
==================

Not applicable.

Ethics approval and consent to participate {#FPar5}
==========================================

Not applicable.

Funding {#FPar6}
=======

This work was supported by donations from Fondazione Umano Progresso and from other donors acknowledged below which supported the purchase of the hardware and software that were necessary to conduct the research.

Fellowships for AP and MC have been mainly funded by the Fondazione Umano Progresso, Milano, Italy. The fellowship for FA has been mainly funded by donations from 'Gruppo Arzdore', Dozza, (BO), Italy and by the Natali family, Petriolo (MC), Italy, in memory of Leonardo Natali.

The funding sources had no role in the design of this study and collection, analysis, and interpretation of data and in writing the manuscript.

Publisher's Note {#FPar7}
================

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
